Could a simpler biopsy replace major surgery for inflammatory breast cancer?

NCT ID NCT07080944

Recruiting now Knowledge-focused Sponsor: European Institute of Oncology Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a less invasive procedure called sentinel lymph node biopsy can be safely used after chemotherapy in people with inflammatory breast cancer. Traditionally, these patients need more extensive surgery because the cancer is advanced. The study will check how often the sentinel node can be found and track long-term outcomes like cancer return. About 75 women whose cancer responded well to chemotherapy will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INVASIVE BREAST CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

inflammatory breast carcinoma invasive breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INVASIVE BREAST CARCINOMA NEOADJUVANT CHEMOTHERAPY SENTINEL LYMPH NODE BIOPSY (SLNB)

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

European Institute of Oncology
RECRUITING

Milan, 20141, Italy

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact